Source: Pharamceutical Technology

ADVANZ PHARMA: Advanz Pharma's liver disease drug pulled from European market after court hearing

This latest update comes after Advanz secured a suspension of the European Commission's original revocation in September 2024.

Read full article »
ADVANZ PHARMA's Competitors | ADVANZ PHARMA's News | ADVANZ PHARMA's Financials
Stay up-to-date with the latest news on ADVANZ PHARMA
Est. Annual Revenue
$100-500M
Est. Employees
500-1.0K
Steffen Wagner's photo - CEO of ADVANZ PHARMA

CEO

Steffen Wagner

CEO Approval Rating

82/100

Read more
Stay up-to-date with the latest news on ADVANZ PHARMA